Lähteenmäki K, Virkola R, Pouttu R, Kuusela P, Kukkonen M, Korhonen T K
Department of General Microbiology, University of Helsinki, Finland.
Infect Immun. 1995 Sep;63(9):3659-64. doi: 10.1128/iai.63.9.3659-3664.1995.
The potential of bacterium-bound plasmin to degrade mammalian extracellular matrix and to enhance bacterial penetration through basement membrane was assessed with the adherent strain SH401-1 of Salmonella enterica serovar Typhimurium. Typhimurium SH401-1 was able to bind plasminogen and to enhance the tissue-type plasminogen activator-mediated activation of the single-chain plasminogen to the two-chain plasmin. The end product, the enzymatically active, bacterium-bound plasmin activity, was also formed in a normal human plasma milieu in the presence of exogenous tissue-type plasminogen activator, indicating that plasmin was protected from the plasminogen activator inhibitors and plasmin inhibitors of plasma. Plasmin bound on Typhimurium cells degraded 125I-labeled laminin as well as 3H-labeled extracellular matrix prepared from the human endothelial cell line EA.hy926. The degradations were not seen with Typhimurium cells without plasminogen and were inhibited by the low-molecular-weight plasmin inhibitor aprotinin. Plasmin bound on Typhimurium cells also potentiated penetration of bacterial cells through the basement membrane preparation Matrigel reconstituted on membrane filters. The results give in vitro evidence for degradation of the mammalian extracellular matrix by bacterium-bound plasmin and for a pathogenetic role for bacterial plasminogen receptors.
利用鼠伤寒沙门氏菌的粘附菌株SH401-1评估了结合细菌的纤溶酶降解哺乳动物细胞外基质以及增强细菌穿透基底膜的潜力。鼠伤寒沙门氏菌SH401-1能够结合纤溶酶原,并增强组织型纤溶酶原激活剂介导的单链纤溶酶原向双链纤溶酶的激活。在存在外源性组织型纤溶酶原激活剂的正常人血浆环境中也形成了终产物,即具有酶活性的、结合细菌的纤溶酶活性,这表明纤溶酶免受血浆中纤溶酶原激活剂抑制剂和纤溶酶抑制剂的影响。结合在鼠伤寒沙门氏菌细胞上的纤溶酶降解了125I标记的层粘连蛋白以及由人内皮细胞系EA.hy926制备的3H标记的细胞外基质。没有纤溶酶原的鼠伤寒沙门氏菌细胞未见降解,且降解被低分子量纤溶酶抑制剂抑肽酶抑制。结合在鼠伤寒沙门氏菌细胞上的纤溶酶还增强了细菌细胞穿透在膜滤器上重构的基底膜制剂基质胶的能力。这些结果为结合细菌的纤溶酶降解哺乳动物细胞外基质以及细菌纤溶酶原受体的致病作用提供了体外证据。